Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 22:12:630051.
doi: 10.3389/fimmu.2021.630051. eCollection 2021.

Case Report: A Case of Acute Cellular Rejection Due to Atopic Dermatitis Exacerbation 3 Years After Heart Transplantation

Affiliations
Case Reports

Case Report: A Case of Acute Cellular Rejection Due to Atopic Dermatitis Exacerbation 3 Years After Heart Transplantation

Nobutaka Kakuda et al. Front Immunol. .

Abstract

Background: Little evidence has been presented about the association between previous atopic/allergic disease and graft rejection after solid organ transplantation. Thus, we present a case wherein acute cellular rejection (ACR) after heart transplantation (HTx) was noted along with exacerbation of atopic disease.

Case summary: A 32-year-old man was admitted at our hospital for regular monitoring of graft rejection. He had undergone heart transplant 3 years prior due to dilated cardiomyopathy. Echocardiogram revealed good biventricular function, and no abnormal findings were found in blood sampling tests. However, biopsy showed moderate ACR [Grade 2R(ISHLT 2004)/3A(ISHLT 1990)], which required twice-repeated steroid pulses with intensified immunosuppression. Meanwhile, his atopic dermatitis, which was diagnosed before having heart failure, was getting worse for the past 6 months. The exacerbation of atopic dermatitis was presumed to be related to the development of the intractable cellular rejection.

Discussion: This case suggested the association of atopic disease and graft rejection after HTx. We examined 76 patients from a cohort of previous studies who underwent HTx at our hospital, which suggested that patients with atopic/allergic disorders such as atopic dermatitis and asthma tended to have a significantly higher frequency of moderate rejection than non-allergic patients. (p = 0.012; Fisher's exact test). Our case also suggests that exacerbation of atopic dermatitis might cause graft rejection of the transplanted organ, so that it is important to carefully evaluate the risk of graft rejection if there is a previous history of atopic/allergic disease.

Keywords: acute cellular rejection; atopic dermatitis; heart transplantation; late rejection of graft; regulatory T cell.

PubMed Disclaimer

Conflict of interest statement

EA and MH belong to the Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo, which is endowed by Actelion Pharmaceuticals Japan Ltd., Otsuka Pharmaceutical, NIPRO CORPORATION, Terumo Corp., Senko Medical Instrument Mfg., Century Medical Inc., Kinetic Concepts Inc., and St. Jude Medical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Hematoxylin and eosin stain of endocardial biopsy sample featuring myocyte injury with multiple lymphocytic infiltration. [Grade2R(ISHLT 2004)/3A(ISHLT 1990)]. (A) First endocardial biopsy (B) Second endocardial biopsy.
Figure 2
Figure 2
Difference in the development of acute cellular rejection within one year after heart transplantation (HTx) and three years after HTx between patients with and without previous allergic disease. NS, not significant.
Figure 3
Figure 3
Kaplan-Meier survival curve of patients with and without previous allergic disease after heart transplantation. There was no significant difference in survival curves between two groups (Log-rank p = 0.53).

Similar articles

References

    1. Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E. Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transpl (2009) 9(5):1017–26. 10.1111/j.1600-6143.2009.02603.x - DOI - PMC - PubMed
    1. Nguyen NX, Martus P, Seitz B, Cursiefen C. Atopic dermatitis as a risk factor for graft rejection following normal-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol (2009) 247(4):573–4. 10.1007/s00417-008-0959-4 - DOI - PubMed
    1. Miura K, Inoue K, Ogura A, Kaminuma O. Role of CD4+ T cells in Airway Diseases: learning from Murine Models. Int J Mol Sci (2020) 21(20):7480. 10.3390/ijms21207480 - DOI - PMC - PubMed
    1. Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E. Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and Th2 alloimmune responses. J Immunol (2010) 184(11):6076–83. 10.4049/jimmunol.0902300 - DOI - PMC - PubMed
    1. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, et al. . Prevention of acute and chronic allograft rejection with CD4+CD25+FOxp3+ regulatory T lymphocytes. Nat Med (2008) 14(1):88–92. 10.1038/nm1688 - DOI - PMC - PubMed

Publication types

Substances